-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QxBiDW8RmZpP+WYK9b0S7NFEOfhiBImAExLWwMbd8nn622s4CCosTa92ahA7xDdR fUBl/qv50nM1P7vUex/lbg== 0001104659-08-012063.txt : 20080221 0001104659-08-012063.hdr.sgml : 20080221 20080221161206 ACCESSION NUMBER: 0001104659-08-012063 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080221 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080221 DATE AS OF CHANGE: 20080221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ON ASSIGNMENT INC CENTRAL INDEX KEY: 0000890564 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] IRS NUMBER: 954023433 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20540 FILM NUMBER: 08633140 BUSINESS ADDRESS: STREET 1: 26651 WEST AGOURA ROAD CITY: CALABASAS STATE: CA ZIP: 91302 BUSINESS PHONE: 8188787900 8-K 1 a08-6252_18k.htm 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 21, 2008

 

On Assignment, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-20540

 

95-4023433

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

26651 West Agoura Road, Calabasas, California

 

91302

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (818) 878-7900

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o        Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o        Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o        Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o        Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 2.02 Results of Operations and Financial Condition.

 

On February 21, 2008, On Assignment, Inc. announced its financial results for the fourth quarter of 2007. A copy of the press release is furnished with this Current Report on Form 8-K as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)

 

The following exhibit is furnished pursuant to Item 2.02:

 

 

 

 

 

99.1

Press release of On Assignment, Inc. dated February 21, 2008, reporting its financial results for the fourth quarter of 2007.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

On Assignment, Inc.

 

 

 

Date: February 21, 2008

 

/s/ James Brill

 

 

James Brill

 

 

Sr. Vice President, Finance and

 

 

Chief Financial Officer

 

3


EX-99.1 2 a08-6252_1ex99d1.htm EX-99.1
Exhibit 99.1
 

 

For Release

 

 

February 21, 2008

 

 

1:00 p.m. PDT

 

 

 

Contacts:

Jim Brill

SVP, Finance and Chief Financial Officer

(818) 878-7900

 

On Assignment Reports Fourth Quarter and Full Year 2007 Results

Full Year 2007 Revenues Increased to a record $567.2 Million

Fourth Quarter Revenues of $152.0 Million Exceeded Company Guidance

 

CALABASAS, Calif., February 21, 2008 — On Assignment, Inc. (NASDAQ: ASGN), a diversified professional staffing firm providing flexible and permanent staffing solutions in specialty skills including Laboratory/Scientific, Healthcare/Nursing, Physicians, Medical Financial, Information Technology and Engineering, today reported results for the quarter and year ended December 31, 2007.

 

Fourth Quarter 2007 Financial Comparisons and Analysis

 

·                  Revenues for the fourth quarter of 2007 were $152.0 million, up 98.7% from the fourth quarter of 2006 and above the high-end of the Company’s previously-announced estimate of $148.0 million. The fourth quarter included $2.6 million in revenues from two long-standing customers experiencing labor disruptions, of which $1.0 million was included in the Company’s fourth quarter estimates.

·                  Gross margins were 31.8%, up from 27.2% in the fourth quarter of 2006.

·                  Net income was $2.2 million, or $0.06 per share, in line with the Company’s previously-announced estimates of $0.06 to $0.09 per share.  Net income for the quarter included the effects of the following unanticipated items:

·                  Executive severance of $531,000 incurred in connection with the separation of the President of the Healthcare Staffing Division

·                  Write-off of $268,000 of in process capitalized software development costs of the IT and Engineering segment

·                  A non-cash expense of $722,000 related to the mark-to-market of the Company’s $73 million interest rate swap

·                  Adjustments to the full year income tax provision that increased the effective tax rate to 44.6% for the full year and to 53.1% for the fourth quarter

·                  Net Income for the fourth quarter of 2006 was $6.1 million, or $0.20 per share, which included $3.0 million in net income related to the reversal of a valuation allowance on deferred tax assets and $392,000 in expense ($0.2 million net of tax) related to severance of a former executive.

·                  Excluding $799,000 in unanticipated items related to executive severance and the write-off of software development costs, discussed above, Adjusted EBITDA (a non-GAAP measurement defined below) was $15.6 million for the fourth quarter of 2007 compared with $6.4 million for the same period in 2006, which also excludes $392,000 in expense related to executive severance.

 

Included in the Company’s 2007 fourth quarter results was net interest expense of $2.5 million versus interest income of $800,000 in the fourth quarter of 2006. The company’s tax rate for the fourth quarter of 2007 was 53.1%, compared with a tax benefit of 38.2% in the fourth quarter of 2006.

 



 

For the fourth quarter of 2007, the Life Sciences segment revenues were $35,134,000, up 12.1% from $31,346,000 in the same period of 2006. The Healthcare segment revenues, which include Nurse Travel and Allied Healthcare lines of business, were down 2.1% to $44,254,000 compared with $45,183,000 in the same period of 2006.  Nurse Travel revenues of $31,366,000, which included $2,649,000 in revenues derived from supporting two long standing customers experiencing labor disruptions, were down 2.0% from $31,997,000 in the same period of 2006. Allied Healthcare revenues were down 2.3% to $12,888,000 from $13,186,000 in the same period of 2006. The Physician segment had revenues of $19,362,000, an increase of 14.6% over the pro-forma fourth quarter revenue of 2006, and the IT and Engineering segment revenues were $53,290,000, an increase of 16.1% over the pro-forma fourth quarter of 2006. The Physician and IT and Engineering segments were businesses acquired by the Company in early 2007.

 

Peter Dameris, President and Chief Executive Officer of On Assignment, Inc., said, “We are very pleased with our financial and operating performance in the fourth quarter and for the full-year 2007.  This was a year of significant growth and achievement for On Assignment. Through two strategic acquisitions, we entered the physician, IT and engineering staffing markets. Both of our acquisitions performed extremely well, and we have enhanced their operating margins over their historical levels.  For the full year we increased our gross margin by 460 basis points to 31.7% and our Adjusted EBITDA was up 200%.  Our earnings per share of $0.26 included $0.25 per share in non-cash expenses related to amortization of identifiable intangibles from the acquisitions and the mark-to-market of our $73 million interest rate swap.” Dameris concluded, “We remain focused on improving the performance of our Healthcare segment and diversifying our Nurse Travel customer base. In the fourth quarter of 2007, we reduced revenues derived from our top ten Nurse Travel customers to 28% of the division’s revenue, down from 48% in the fourth quarter of 2006.”

 

Jim Brill, Senior Vice President and Chief Financial Officer of On Assignment, Inc. stated, “Our fourth quarter gross margins were 31.8%, up significantly from 27.2% in last year’s fourth quarter. Although a portion of this increase related to the higher gross margins in our acquired businesses, each of our segments saw year-over-year increases. In the fourth quarter of 2007, gross margins in Life Sciences increased to 33.2% from 33.0% in 2006, and Healthcare gross margins increased to 25.7% from 23.1%. Our Physician segment and IT and Engineering segment gross margins remained strong at 27.4% and 37.5%, respectively.

 

We demonstrated our ability to generate cash, ending the quarter with $37.8 million in cash and cash equivalents, up from $37.0 million in the third quarter. Additionally, during the fourth quarter we used $8 million to reduce our bank loan to $135.9 million and approximately $2.0 million to repurchase 278,000 shares of our stock. Amortization of intangibles was $3.7 million, depreciation was $1.7 million and equity-based compensation expense was $1.6 million.”

 

First Quarter 2008 Financial Guidance

Based on revenues in the first six weeks of the first quarter of 2008, taking into account the Company’s normal seasonal patterns and assuming no deterioration in the staffing markets On Assignment serves, the Company provided the following financial guidance for the quarter ending March 31, 2008:

 

·                  Revenues of $146.5 to $149.5 million

·                  Gross Margins of 31.1% to 31.5% including the reset of employment taxes

·                  SG&A of $39.0 to $40.0 million, including depreciation of approximately $1.5 million, amortization of approximately $2.4 million and approximately $1.5 million in equity based compensation expense

·                  Adjusted EBITDA of $11.0 to $13.5 million

·                  Net income of $2.0 to $3.4 million

·                  Earnings per share of $0.06 to $0.10

 

On Assignment will hold its quarterly conference call to discuss its fourth quarter and full year 2007 financial results this afternoon, Thursday February 21, 2008 at 1:30 p.m. Pacific Time.  Interested parties are invited to listen to the conference call by dialing (800) 309-8283 or (706) 634-1958 ten minutes before the call. The conference code is 32583192. A replay of the conference call can be accessed from approximately 2:30 p.m. Pacific Time Thursday February 21, 2008 through Friday February 29, 2008 by dialing (800) 642-1687 or (706) 645-9291 with the access code 32583192.

 



 

This call is being webcast by Thomson/CCBN and can be accessed via On Assignment’s web site at www.onassignment.com.  Individual investors can also listen at Thomson/CCBN’s site at www.fulldisclosure.com or by visiting any of the investor sites in Thomson/CCBN’s Individual Investor Network.  Institutional investors can access the call via Thomson/CCBN’s password-protected event management site, StreetEvents at www.streetevents.com.

 

About On Assignment

On Assignment, Inc. is a diversified professional staffing firm providing flexible and permanent staffing solutions in specialty skills including Laboratory/Scientific, Healthcare/Nursing/Physicians, Medical Financial, Information Technology and Engineering. The corporate headquarters are located in Calabasas, California.  On Assignment, Inc. was founded in 1985 as On Assignment/Lab Support and went public in 1992.  The Company’s branch network encompasses approximately 80 branch offices across the United States, United Kingdom, Netherlands, Ireland and Belgium and also provides physicians in Australia and New Zealand.

 

Reasons for Presentation of Non-GAAP Financial Measures

Statements made in this release and the Supplemental Financial Information accompanying this release include non-GAAP financial measures.  Such information is provided as additional information, not as an alternative to our consolidated financial statements presented in accordance with GAAP, and is intended to enhance an overall understanding of our current financial performance.  The Supplemental Financial Information sets forth financial measures reviewed by our management to evaluate our operating performance.  Such measures also are used to determine a portion of the compensation for some of our executives and employees.  We believe the non-GAAP financial measures provide useful information to management, investors and prospective investors by excluding certain charges and other amounts that we believe are not indicative of our core operating results.  These non-GAAP measures are included to provide management, our investors and prospective investors with an alternative method for assessing our operating results in a manner that is focused on the performance of our ongoing operations and to provide a more consistent basis for comparison between quarters.  One of the non-GAAP financial measures presented is EBITDA (earnings before interest, taxes, depreciation, amortization of identifiable intangible assets), another term is Adjusted EBITDA (EBITDA plus equity-based compensation expense), another is Adjusted EBITDA Excluding Executive Severance and Software Write-Off which terms might not be calculated in the same manner as, and thus might not be comparable to, similarly titled measures reported by other companies.  The financial statement tables that accompany this press release include reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure.

 

Safe Harbor

Certain statements made in this news release are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and involve a high degree of risk and uncertainty.  Forward-looking statements include statements regarding the Company’s anticipated financial and operating performance in 2008.  All statements in this release, other than those setting forth strictly historical information, are forward-looking statements.  Forward-looking statements are not guarantees of future performance, and actual results might differ materially.  In particular, the Company makes no assurances that the estimates of revenues, gross margins, SG&A, adjusted EBITDA, net income or earnings per share set forth above will be achieved. Factors that could cause or contribute to such differences include actual demand for our services, our ability to attract, train and retain qualified staffing consultants, our ability to remain competitive in obtaining and retaining temporary staffing clients, the availability of qualified temporary nurses and other qualified temporary professionals, management of our growth, continued performance of our enterprise-wide information systems, and other risks detailed from time to time in our reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2006, as filed with the SEC on March 16, 2007 and quarterly reports on Form 10Q for the quarters ended March 31, 2007, June 30, 2007 and September 30, 2007 as filed with the SEC on May 10, 2007, August 9, 2007 and November 9, 2007 respectively.  We specifically disclaim any intention or duty to update any forward-looking statements contained in this news release.

 



 

SUMMARY CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(unaudited)

 

 

 

Quarter Ended

 

Twelve Months Ended

 

 

 

December 31,
 2007

 

December 31,
 2006

 

September 30,
 2007

 

December 31,
 2007

 

December 31,
 2006

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

152,040

 

$

76,529

 

$

148,657

 

$

567,180

 

$

287,566

 

Cost of Services

 

103,731

 

55,720

 

101,130

 

387,643

 

209,725

 

Gross Profit

 

48,309

 

20,809

 

47,527

 

179,537

 

77,841

 

Selling, General and Administrative Expenses

 

40,363

 

17,204

 

38,326

 

151,942

 

67,900

 

Operating Income

 

7,946

 

3,605

 

9,201

 

27,595

 

9,941

 

Interest Expense

 

(2,904

)

 

(2,940

)

(10,968

)

(54

)

Interest Income

 

412

 

829

 

344

 

1,394

 

1,698

 

Other Expense

 

(722

)

 

(915

)

(1,206

)

 

Pre-tax Income

 

4,732

 

4,434

 

5,690

 

16,815

 

11,585

 

Income Tax Provision (Benefit)

 

2,514

 

(1,695

)

2,435

 

7,493

 

541

 

Net Income

 

$

2,218

 

$

6,129

 

$

3,255

 

$

9,322

 

$

11,044

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted Earnings Per Share

 

$

0.06

 

$

0.20

 

$

0.09

 

$

0.26

 

$

0.39

 

Weighted Average Common and Common Equivalent Shares Outstanding—Diluted

 

35,759

 

31,066

 

35,886

 

35,771

 

28,052

 

 



 

SUPPLEMENTAL FINANCIAL INFORMATION

(In thousands)

(unaudited)

 

 

 

Quarter Ended

 

Twelve Months Ended

 

 

 

December 31,
 2007

 

December 31,
 2006

 

September 30,
 2007

 

December 31,
 2007

 

December 31,
 2006

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

Life Sciences Segment

 

$

35,134

 

$

31,346

 

$

34,431

 

$

134,622

 

$

117,462

 

 

 

 

 

 

 

 

 

 

 

 

 

Healthcare Staffing Segment

 

44,254

 

45,183

 

44,524

 

175,079

 

170,104

 

 

 

 

 

 

 

 

 

 

 

 

 

Physician Staffing Segment

 

19,362

 

 

19,138

 

74,599

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IT and Engineering Segment

 

53,290

 

 

50,564

 

182,880

 

 

Consolidated Revenues

 

$

152,040

 

$

76,529

 

$

148,657

 

$

567,180

 

$

287,566

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit:

 

 

 

 

 

 

 

 

 

 

 

Life Sciences Segment

 

$

11,663

 

$

10,357

 

$

11,585

 

$

45,024

 

$

38,143

 

 

 

 

 

 

 

 

 

 

 

 

 

Healthcare Staffing Segment

 

11,387

 

10,452

 

11,295

 

44,269

 

39,698

 

 

 

 

 

 

 

 

 

 

 

 

 

Physician Staffing Segment

 

5,297

 

 

5,564

 

21,808

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IT and Engineering Segment

 

19,962

 

 

19,083

 

68,436

 

 

Consolidated Gross Profit

 

$

48,309

 

$

20,809

 

$

47,527

 

$

179,537

 

$

77,841

 

 

SELECTED CASH FLOW INFORMATION

(In thousands)

(unaudited)

 

 

 

Quarter Ended

 

Twelve Months Ended

 

 

 

December 31,
 2007

 

December 31,
 2006

 

September 30,
 2007

 

December 31,
 2007

 

December 31,
 2006

 

Cash provided by Operations

 

11,306

 

2,422

 

8,506

 

33,658

 

14,302

 

Capital Expenditures

 

1,560

 

1,057

 

1,685

 

5,899

 

4,111

 

 



 

SELECTED CONSOLIDATED BALANCE SHEET DATA

(In thousands)

(unaudited)

 

 

 

As of

 

 

 

December 31,
 2007

 

December 31,
 2006

 

September 30,
 2007

 

Cash and Cash Equivalents

 

$

 37,764

 

$

 110,161

 

$

 37,042

 

Accounts Receivable, net

 

78,840

 

39,107

 

81,783

 

Intangible Assets, net

 

234,516

 

17,776

 

231,668

 

Total Assets

 

386,892

 

186,995

 

383,203

 

Bank Debt – Current Portion

 

 

 

1,450

 

Current Liabilities

 

50,843

 

20,424

 

43,389

 

Bank Debt – Long Term

 

135,913

 

 

142,463

 

Other Long Term Liabilities

 

7,102

 

627

 

5,891

 

Stockholders’ Equity

 

193,034

 

165,944

 

191,460

 

 

RECONCILIATION OF GAAP NET INCOME AND EARNINGS PER SHARE TO NON-GAAP EBITDA AND EBITDA PER SHARE

(In thousands, except per share amounts)

(unaudited)

 

 

 

Quarter Ended

 

 

 

December 31,
 2007

 

December 31,
 2006

 

September 30,
 2007

 

Net Income

 

$

 2,218

 

$

 0.06

 

$

 6,129

 

$

 0.20

 

$

 3,255

 

$

 0.09

 

Other Expense

 

722

 

0.02

 

 

 

915

 

0.03

 

Interest Expense (Income), net

 

2,492

 

0.07

 

(829

)

(0.03

)

2,596

 

0.07

 

Income Tax Provision (Benefit)

 

2,514

 

0.07

 

(1,695

)

(0.05

)

2,435

 

0.07

 

Depreciation

 

1,678

 

0.05

 

1,080

 

0.03

 

1,624

 

0.05

 

Amortization of Intangibles

 

3,654

 

0.10

 

242

 

0.01

 

3,745

 

0.10

 

EBITDA

 

13,278

 

0.37

 

4,927

 

0.16

 

14,570

 

0.41

 

Equity-based compensation

 

1,550

 

0.04

 

1,077

 

0.03

 

1,472

 

0.04

 

Adjusted EBITDA

 

$

14,828

 

$

0.41

 

$

6,004

 

$

0.19

 

$

16,042

 

$

0.45

 

Executive Severance

 

531

 

0.02

 

392

 

0.02

 

 

 

Software Write-Off

 

268

 

0.01

 

 

 

 

 

Adjusted EBITDA excluding Executive Severance and Software Write-Off

 

$

15,627

 

$

0.44

 

$

6,396

 

$

0.21

 

$

16,042

 

$

0.45

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common and Common Equivalent Shares Outstanding

 

35,759

 

 

 

31,066

 

 

 

35,886

 

 

 

 



 

 

 

Twelve Months Ended

 

 

 

December 31,
 2007

 

December 31,
 2006

 

Net Income

 

$

 9,322

 

$

 0.26

 

$

 11,044

 

$

 0.39

 

Other Expense

 

1,206

 

0.03

 

 

 

Interest Expense (Income), net

 

9,574

 

0.27

 

(1,644

)

(0.05

)

Income Tax Provision

 

7,493

 

0.21

 

541

 

0.02

 

Depreciation

 

6,194

 

0.17

 

4,672

 

0.17

 

Amortization of Intangibles

 

15,342

 

0.43

 

957

 

0.03

 

EBITDA

 

49,131

 

1.37

 

15,570

 

0.56

 

Equity-based Compensation

 

6,359

 

0.18

 

2,953

 

0.10

 

Adjusted EBITDA

 

$

55,490

 

$

1.55

 

$

18,523

 

$

0.66

 

Executive Severance

 

531

 

0.01

 

392

 

0.01

 

Software Write-Off

 

268

 

0.01

 

 

 

Adjusted EBITDA excluding Executive Severance and Software Write-Off

 

$

56,289

 

$

1.57

 

$

18,915

 

$

0.67

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common and Common Equivalent Shares Outstanding

 

35,771

 

 

 

28,052

 

 

 

 

RECONCILIATION OF ESTIMATED GAAP NET INCOME TO ESTIMATED NON-GAAP EBITDA AND ADJUSTED EBITDA

(In thousands)

(unaudited)

 

 

 

Estimated Range

 

 

 

Quarter Ending

 

 

 

March 31, 2008

 

Net Income

 

$

2,000

 

$

3,400

 

Interest Expense

 

2,100

 

2,100

 

Income Tax Provision

 

1,500

 

2,600

 

Depreciation and Amortization

 

3,900

 

3,900

 

EBITDA

 

9,500

 

12,000

 

Equity-based Compensation

 

1,500

 

1,500

 

Adjusted EBITDA

 

$

11,000

 

$

13,500

 

 



 

SUPPLEMENTAL FINANCIAL INFORMATION – REVENUES AND GROSS MARGINS

(Unaudited)

(In thousands, except percentages)

 

 

 

 

 

Healthcare

 

 

 

 

 

 

 

 

 

Life
Sciences

 

Allied
Healthcare

 

Nurse
Travel

 

Total
Healthcare

 

Physician 
Staffing

 

IT and
Engineering

 

Consolidated

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Q4 2007

 

35,134

 

12,888

 

31,366

 

44,254

 

19,362

 

53,290

 

152,040

 

Q3 2007

 

34,431

 

13,698

 

30,826

 

44,524

 

19,138

 

50,564

 

148,657

 

% Sequential Growth

 

2.0

%

(5.9

)%

1.8

%

(0.6

)%

1.2

%

5.4

%

2.3

%

Q4 2006 (Pro-Forma)(1)

 

31,346

 

13,186

 

31,997

 

45,183

 

16,895

(1)

45,910

(1)

139,334

(1)

% Year over Year Growth

 

12.1

%

(2.3

)%

(2.0

)%

(2.1

)%

14.6

%

16.1

%

9.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Margins:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Q4 2007

 

33.2

%

31.0

%

23.5

%

25.7

%

27.4

%

37.5

%

31.8

%

Q3 2007

 

33.6

%

32.3

%

22.3

%

25.4

%

29.1

%

37.7

%

32.0

%

Q4 2006

 

33.0

%

28.4

%

21.0

%

23.1

%

(2)

(2)

27.2

%

 


(1) Pro-Forma amounts represent 2006 results as if the acquisitions of Vista and Oxford had occurred as of January 1, 2006

 

(2) Comparative amounts for Vista and Oxford not available for this period

 



 

(Unaudited)

 

SUPPLEMENTAL FINANCIAL INFORMATION – KEY METRICS

 

 

 

For the Quarter Ended

 

 

 

December 31,
 2007

 

September 30,
 2007

 

Percentage of Revenues:

 

 

 

 

 

Top Ten Clients

 

7.4

%

8.2

%

Direct Hire/Conversion

 

1.7

%

2.0

%

 

 

 

 

 

 

Bill Rate Increase:

 

 

 

 

 

% Sequential Growth

 

0.1

%

3.6

%

% Year-over-Year Growth

 

50.8

%

51.1

%

 

 

 

 

 

 

Bill/Pay Spread:

 

 

 

 

 

% Sequential Growth

 

(0.8

)%

4.5

%

% Year-over-Year Growth

 

48.6

%

50.5

%

 

 

 

 

 

 

Average Headcount:

 

 

 

 

 

Contract Professionals (CP)

 

5,069

 

4,990

 

Staffing Consultants (SC)

 

773

 

755

 

 

 

 

 

 

 

Productivity:

 

 

 

 

 

Gross Profit per SC

 

62,000

 

63,000

 

 


-----END PRIVACY-ENHANCED MESSAGE-----